Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL151 versus placebo in perennial allergic rhinitis (4-week, multicenter, randomized, double-blind, parallel, phase 3)
KCT0003974Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Belion CR in perennial rhinitis, sponsored by Hanlim Pharm. Started Jan 2017; status: completed.
02
Drugs
Belion CR
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on KCT0003974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003974.